These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 8943798

  • 1. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease.
    Khaw KT.
    J Endocrinol; 1996 Sep; 150 Suppl():S149-53. PubMed ID: 8943798
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer.
    Alberg AJ, Gordon GB, Hoffman SC, Comstock GW, Helzlsouer KJ.
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):517-21. PubMed ID: 10815698
    [Abstract] [Full Text] [Related]

  • 5. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [Abstract] [Full Text] [Related]

  • 6. Plasma levels of estradiol, testosterone, and DHEAS do not predict risk of coronary artery disease in men.
    Contoreggi CS, Blackman MR, Andres R, Muller DC, Lakatta EG, Fleg JL, Harman SM.
    J Androl; 1990 Mar; 11(5):460-70. PubMed ID: 2147671
    [Abstract] [Full Text] [Related]

  • 7. The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study.
    Saruç M, Yüceyar H, Ayhan S, Türkel N, Tuzcuoglu I, Can M.
    Hepatogastroenterology; 2003 Mar; 50(51):771-4. PubMed ID: 12828082
    [Abstract] [Full Text] [Related]

  • 8. Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects.
    Martina V, Benso A, Gigliardi VR, Masha A, Origlia C, Granata R, Ghigo E.
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):260-4. PubMed ID: 16487434
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical response.
    Barry NN, McGuire JL, van Vollenhoven RF.
    J Rheumatol; 1998 Dec; 25(12):2352-6. PubMed ID: 9858429
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
    Tworoger SS, Missmer SA, Eliassen AH, Spiegelman D, Folkerd E, Dowsett M, Barbieri RL, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
    [Abstract] [Full Text] [Related]

  • 13. Are low dehydroepiandrosterone sulphate levels predictive for cardiovascular diseases? A review of prospective and retrospective studies.
    Thijs L, Fagard R, Forette F, Nawrot T, Staessen JA.
    Acta Cardiol; 2003 Oct; 58(5):403-10. PubMed ID: 14609305
    [Abstract] [Full Text] [Related]

  • 14. [The relationship between serum dehydroepiandrosterone sulfate levels and factors associated with cardiovascular diseases: a cross-sectional study in Japan].
    Okamoto K, Yagyu K, Sasaki R.
    Nihon Koshu Eisei Zasshi; 1995 Feb; 42(2):78-83. PubMed ID: 7718911
    [Abstract] [Full Text] [Related]

  • 15. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
    Dorgan JF, Stanczyk FZ, Longcope C, Stephenson HE, Chang L, Miller R, Franz C, Falk RT, Kahle L.
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):177-81. PubMed ID: 9138660
    [Abstract] [Full Text] [Related]

  • 16. The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods.
    von Mühlen D, Laughlin GA, Kritz-Silverstein D, Barrett-Connor E.
    Contemp Clin Trials; 2007 Feb; 28(2):153-68. PubMed ID: 16784898
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Independent association between insulin-like growth factor-I and dehydroepiandrosterone sulphate in women in middle adulthood.
    Kasayama S, Morita S, Otsuki M, Asanuma N, Saito H, Mukai M, Koga M.
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):797-802. PubMed ID: 17381481
    [Abstract] [Full Text] [Related]

  • 19. Dehydroepiandrosterone sulfate and breast cancer risk.
    Barrett-Connor E, Friedlander NJ, Khaw KT.
    Cancer Res; 1990 Oct 15; 50(20):6571-4. PubMed ID: 2145063
    [Abstract] [Full Text] [Related]

  • 20. Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients.
    Aldred S, Mecocci P.
    Arch Gerontol Geriatr; 2010 Oct 15; 51(1):e16-8. PubMed ID: 19665809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.